4/A
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001562180-19-006291
See Remarks sold 12,083 shares at an average $16.01 ($193,473)
- See Remarks acquired 5,001 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZDRAVESKI ZORAN See Remarks | 2019-12-23 | Option exercise | +9 | $7.71 | $69 | 140,101 | D |
| ZDRAVESKI ZORAN See Remarks | 2019-12-23 | Option exercise | +4,172 | $9.49 | $39,592 | 144,273 | D |
| ZDRAVESKI ZORAN See Remarks | 2019-12-23 | Sale | −4,181 | $16.03 | $67,041 | 140,092 | D |
| ZDRAVESKI ZORAN See Remarks | 2019-12-24 | Option exercise | +820 | $7.71 | $6,322 | 140,912 | D |
| ZDRAVESKI ZORAN See Remarks | 2019-12-24 | Sale | −7,902 | $16.00 | $126,432 | 133,010 | D |
| Derivatives | |||||||
| ZDRAVESKI ZORAN See Remarks | 2019-12-23 | Option exercise · Stock Option (Right to Buy) | −4,172 | 129,342 | D | ||
| ZDRAVESKI ZORAN See Remarks | 2019-12-23 | Option exercise · Stock Option (Right to Buy) | −9 | 17,676 | D | ||
| ZDRAVESKI ZORAN See Remarks | 2019-12-24 | Option exercise · Stock Option (Right to Buy) | −820 | 16,856 | D | ||
| Open-market sales · 12,083 sh · avg $16.01 · $193,473 | |||||||
Loading xslF345X03/primarydocument.xml…